Synergistic Effects of Combination Therapies Overcoming Drug Resistance

The increasing global trend in antimicrobial resistance represents an overwhelming threat to public health, with the potential to undermine the effectiveness of standard monotherapies against bacterial, viral, fungal, and parasitic diseases. As bacteria become resistant to single-drug therapy by developing escape mechanisms, such as activation of efflux pumps, alteration of target sites, enzymatic inactivation, and biofilm formation, there is an increasing need to adopt alternate treatment regimens. Combination therapy with two or more pharmacologic agents has become an effective strategy to overcome resistance, improve therapeutic effectiveness, and minimize treatment duration and toxicity. In this chapter, the scientific rationale and clinical relevance of synergistic drug combinations for overcoming resistance mechanisms are examined. It provides a broad overview of the nature of drug interactions, namely synergistic, additive, and antagonistic, with an emphasis on methodologies for assessing such interactions using in vitro, in vivo, and computational models. Case studies on multidrug-resistant bacterial infections, antifungal resistance, and antiviral therapy have been presented for practical applications. This chapter further explores recent developments, such as high-throughput screening, AI-assisted drug synergy prediction, and nanoparticle-mediated combination delivery systems. Although promising, combination therapies are confronted with clinical and regulatory hurdles such as toxicity, pharmacokinetic heterogeneity, and trial design complexity. Targeted combination regimens based on genomic and proteomic profiles will be developed in the future. Combination therapy is a pillar of the relentless war on drug resistance, with its dynamic and flexible nature based on molecular understanding and multidisciplinary ingenuity.